Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Remo Panaccione
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: The CLASSIC-I Trial
Gastroenterology
Hepatology
Gastroenterology
‹
1
2
Related publications
Infliximab (Anti–Tumor Necrosis Factor Α Antibody)
Archives of Dermatology
A Cell-Killing Monoclonal Antibody (Anti-Fas) to a Cell Surface Antigen Co-Downregulated With the Receptor of Tumor Necrosis Factor
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Golimumab: A Novel Anti-Tumor Necrosis Factor
Biologics in Therapy
Recognition of Human Tumor Necrosis Factor Α (TNF-α) by Therapeutic Antibody Fragment
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Selective Improvement of Tumor Necrosis Factor Capture in a Cytokine Hemoadsorption Device Using Immobilized Anti-Tumor Necrosis Factor
Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical Engineering
Biomaterials
Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.
Gut
Gastroenterology
Immunogenicity Negatively Influences the Outcome of Adalimumab Treatment in Crohn’s Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice
International Journal of Cancer
Cancer Research
Oncology
Levels of Intestinal Inflammation and Fibrosis in Resection Specimens After Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients With Crohn’s Disease: A Comparative Pilot Study
Surgery Research and Practice
Nuclear Medicine
Radiology
Imaging
